Try our Advanced Search for more refined results

Allen et al v. Takeda Pharmaceuticals North America Inc et al

  1. February 09, 2015

    Top Product Verdicts Of 2014 — And The Firms That Won Them

    Last year's biggest product liability verdicts included multibillion-dollar decisions with large punitive damages components — a $6 billion award against Takeda Pharmaceutical Co. Ltd. that was later reduced, and a $23 billion Engle verdict against R.J. Reynolds Tobacco Co. — but with appeals still pending, the eye-popping awards face dramatic cuts.

  2. October 30, 2014

    Eli Lilly, Takeda Plan Appeal Of $37M Actos Ruling

    Takeda Pharmaceuticals International Inc. and Eli Lilly & Co. said Thursday they will appeal a $37 million punitive damages ruling against them in a suit that alleged the company hid the cancer risks of diabetes drug Actos to keep sales high.

  3. October 28, 2014

    Actos Ruling Sets Up Appellate Clash Over Punitives Ceiling

    A Louisiana federal judge's ruling slashing a $9 billion Actos bladder cancer award to $37 million highlights an ambiguity on upper limits for punitive damages that attorneys say will spur the Fifth Circuit — and maybe even the U.S. Supreme Court — to address the issue more directly.

  4. October 27, 2014

    $9B Takeda, Eli Lilly Actos Damages Slashed To $37M

    A Louisiana federal judge on Monday slashed a $9 billion punitive damages award against Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. over the diabetes drug Actos to $36.8 million, ruling the jury "should bow" to the Constitution's due process clause.

  5. August 28, 2014

    Takeda, Eli Lilly Stuck With $9B Actos Verdict

    A Louisiana federal judge on Thursday denied a Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. bid to overturn the $9 billion verdict in a bellwether trial over allegations the companies hid the cancer risks of diabetes drug Actos, upholding the jury's punitive damages award.

  6. June 27, 2014

    Takeda, Lilly Say Prejudice Infected $9B Actos Verdict

    Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. argued Friday that the sheer size of the $9 billion punitive damages award they suffered in the bellwether personal injury trial over the diabetes drug Actos demonstrates the jury was inflamed by "passion and prejudice," saying its verdict should be overturned.

  7. June 20, 2014

    Takeda Destroyed Evidence In $9B Cancer Suit, Judge Says

    A Louisiana federal judge said Friday that Takeda Pharmaceuticals Co. Ltd. intentionally destroyed evidence that would have helped the plaintiffs in a $9 billion bellwether lawsuit over claims the company hid the cancer risks of diabetes drug Actos to keep sales high.

  8. April 24, 2014

    Takeda Won't Commit To Cover Eli Lilly For $9B Verdict

    Takeda Pharmaceutical Co. Ltd. isn't conceding that it needs to pay Eli Lilly & Co.'s piece of a $9 billion verdict against the two companies for allegedly hiding the cancer risks of the diabetes drug Actos, the Japan-based drugmaker said Thursday.

  9. April 08, 2014

    $9B Verdict Hammers Takeda, Eli Lilly In Actos Bellwether

    A Louisiana federal jury on Monday ordered Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. to pay more than $9 billion in damages to a couple, in a bellwether trial over allegations the companies hid the cancer risks of diabetes drug Actos to keep sales high.

  10. March 18, 2014

    Eli Lilly Slams Bid To Dredge Up Zyprexa Past In Actos Row

    Eli Lilly & Co. argued in Louisiana district court Monday that the Actos bellwether trial plaintiffs are seeking extreme sanctions over a former executive's testimony on a different drug — one which the drugmaker copped to a criminal charge for in 2009 — simply to tarnish its image with the jury.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!